Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening.

Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening.

The interaction between beta-catenin and Tcf family members is crucial for the Wnt signal transduction pathway, which is commonly mutated in cancer. This interaction extends over a very large surface area (4800 A(2)), and inhibiting such interactions using low molecular weight inhibitors is a challe...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Trosset, J, Dalvit, C, Knapp, S, Fasolini, M, Veronesi, M, Mantegani, S, Gianellini, L, Catana, C, Sundström, M, Stouten, P, Moll, J
Format:	Journal article
Język:	English
Wydane:	2006

Podobne zapisy

Hot spots in Tcf4 for the interaction with beta-catenin.
od: Fasolini, M, i wsp.
Wydane: (2003)

NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands.
od: Dalvit, C, i wsp.
Wydane: (2002)

The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
od: Brennan Marsh-Armstrong, i wsp.
Wydane: (2018-11-01)

Bioavailability Computations for Natural Phenolic Derivatives for Druglikeness Assessment
od: Amalia Stefaniu, i wsp.
Wydane: (2023-11-01)

ADMET and Druglikeness Calculations of Sarin, Soman, and Their Hypothetical Derivatives
od: Kafa Khalaf Hammud
Wydane: (2022-12-01)

Design of Druglike Small Molecules for Possible Inhibition of Antiapoptotic BCL-2, BCL-W, and BFL-1 Proteins
od: D.S. Dalafave
Wydane: (2010-09-01)

Design of Druglike Small Molecules for Possible Inhibition of Antiapoptotic BCL-2, BCL-W, and BFL-1 Proteins
od: D.S. Dalafave
Wydane: (2010-01-01)

Description of Druglike Properties of Safranal and Its Chemistry behind Low Oral Exposure
od: Ashish Dogra, i wsp.
Wydane: (2020-04-01)

Beta-catenin in the melanocyte lineage.
od: Larue, L, i wsp.
Wydane: (2003)

Synthesis of Dihydrouracils Spiro-Fused to Pyrrolidines: Druglike Molecules Based on the 2-Arylethyl Amine Scaffold
od: Daniel Blanco-Ania, i wsp.
Wydane: (2010-03-01)

Synthetic biology for pharmaceutical drug discovery
od: Trosset JY, i wsp.
Wydane: (2015-12-01)

Biophysical and Integrative Characterization of Protein Intrinsic Disorder as a Prime Target for Drug Discovery
od: Shuqi Luo, i wsp.
Wydane: (2023-03-01)

Synthesis, Molecular Docking, Druglikeness Analysis, and ADMET Prediction of the Chlorinated Ethanoanthracene Derivatives as Possible Antidepressant Agents
od: Mujeeb A. Sultan, i wsp.
Wydane: (2020-10-01)

Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1.
od: Sarah H Louie, i wsp.
Wydane: (2009-01-01)

Beta-catenin Forms Protein Aggregation at High Concentrations in HEK293TCells
od: Marie Saghaeian Jazi, i wsp.
Wydane: (2017-01-01)

miDruglikeness: Subdivisional Drug-Likeness Prediction Models Using Active Ensemble Learning Strategies
od: Chenjing Cai, i wsp.
Wydane: (2022-12-01)

Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold
od: Dan Meng, i wsp.
Wydane: (2022-10-01)

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
od: Imra Aqeel, i wsp.
Wydane: (2022-10-01)

ADME/PK Insights of Crocetin: A Molecule Having an Unusual Chemical Structure with Druglike Features
od: Diksha Manhas, i wsp.
Wydane: (2024-05-01)

High-throughput structural characterisation of therapeutic protein targets.
od: Marsden, B, i wsp.
Wydane: (2006)

High-throughput structural characterisation of therapeutic protein targets
od: Marsden, B, i wsp.
Wydane: (2006)

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
od: Rempinski Donald R, i wsp.
Wydane: (2010-12-01)

Thermodynamics of the high-affinity interaction of TCF4 with beta-catenin.
od: Knapp, S, i wsp.
Wydane: (2001)

Biophysical studies of membrane protein structure and function
od: Dijkman, P, i wsp.
Wydane: (2014)

Biophysical and magnetic resonance studies of membrane proteins
od: Orwick, M, i wsp.
Wydane: (2011)

Biophysical characterization of protein-protein interactions with mass photometry
od: Soltermann, F
Wydane: (2020)

Editorial: Insights in protein biochemistry: protein biophysics 2022
od: Nikolaos E. Labrou, i wsp.
Wydane: (2023-04-01)

Combining Bioinformatics and Biophysics to Understand Protein-Protein and Protein-Ligand Interactions
od: Barry Honig
Wydane: (2002-01-01)

Biophysical characterization of proteins in developing biopharmaceuticals /
od: Houde, Damian J., editor, i wsp.
Wydane: (2015)

Biophysical Characterization of Iron-Sulfur Proteins
od: Bhanu Jagilinki, i wsp.
Wydane: (2021-10-01)

Classification of protein–protein association rates based on biophysical informatics
od: Kalyani Dhusia, i wsp.
Wydane: (2021-08-01)

Recent Biophysical Advances in Drug Discovery
od: Ho Leung Ng
Wydane: (2022-06-01)

Biophysical methods in early drug discovery
od: Geoffrey Holdgate, i wsp.
Wydane: (2019-12-01)

Biophysical characterization of high-confidence, small human proteins
od: A.M. Whited, i wsp.
Wydane: (2024-09-01)

Biophysical characterisation of fibulin-5 proteins associated with disease.
od: Schneider, R, i wsp.
Wydane: (2010)

Beta-Catenin in Pseudoexfoliation Syndrome
od: Joanna Stafiej, i wsp.
Wydane: (2020-09-01)

Beta-catenin expression in psoriasis
od: Mohamed Abd El-wahed Gaber, i wsp.
Wydane: (2015-01-01)

Prediction of aqueous intrinsic solubility of druglike molecules using Random Forest regression trained with Wiki-pS0 database
od: Alex Avdeef
Wydane: (2020-03-01)

Structural and biophysical analysis of nuclease protein antibiotics
od: Klein, A, i wsp.
Wydane: (2016)

Biophysical investigations into membrane-active peptides and proteins
od: Yin, D
Wydane: (2016)